Keyphrases
NADPH Oxidase
100%
Receptor-mediated
100%
N-methyl-D-aspartate Receptor (NMDAR)
100%
MK-801
100%
Glomerulosclerosis
100%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
33%
Homocysteine
33%
Matrix metalloproteinase-1 (MMP-1)
33%
Folate
33%
Sprague-Dawley Rats
16%
Kidney
16%
In Vitro Study
16%
Glomerulus
16%
Glomerular Deposition
16%
Receptor Expression
16%
Rat Mesangial Cells
16%
NMDA Receptor Antagonist
16%
Glomerular Injury
16%
Matrix metalloproteinase-9 (MMP-9)
16%
Extracellular Matrix Protein 1 (ECM1)
16%
NADPH Oxidase Activity
16%
Homocysteine Levels
16%
Damage Index
16%
Hypercholesterinemia
16%
Pharmacology, Toxicology and Pharmaceutical Science
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
100%
N Methyl Dextro Aspartic Acid Receptor
100%
Glomerulosclerosis
100%
Homocysteine
42%
Tissue Inhibitor of Metalloproteinase 1
28%
Folic Acid
28%
Interstitial Collagenase
28%
Sprague Dawley Rat
14%
Gelatinase B
14%
N Methyl Dextro Aspartic Acid Receptor Blocking Agent
14%